|
Market Closed -
Nasdaq
06:00:00 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 827.72 USD | -1.87% |
|
+3.58% | +7.24% |
| Market Cap | 82.65B 71.08B 66.85B 61.03B 114B 7,817B 115B 793B 306B 4,003B 310B 304B 12,751B | P/E 2026 * |
19.2x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 75.78B 65.17B 61.3B 55.96B 105B 7,167B 105B 727B 281B 3,670B 285B 278B 11,691B | EV / Sales 2026 * |
4.48x | EV / Sales 2027 * | 3.91x |
| Free-Float |
71.06% | Yield 2026 * |
0.47% | Yield 2027 * | 0.54% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -1.87% | ||
| 1 week | +3.58% | ||
| Current month | +3.58% | ||
| 1 month | +5.53% | ||
| 3 months | +30.26% | ||
| 6 months | +8.93% | ||
| Current year | +7.24% |
| 1 week | 825.77 |  | 859.34 |
| 1 month | 775.83 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.87% | +3.58% | +44.36% | +0.30% | 82.65B | |
| +0.94% | +1.45% | -18.08% | -35.46% | 59.87B | |
| -2.23% | +3.71% | +478.96% | +34.33% | 58.11B | |
| +1.31% | -3.43% | -7.43% | +31.70% | 50.35B | |
| -1.05% | -4.90% | -1.24% | +151.82% | 46.62B | |
| -1.64% | +1.93% | +56.98% | -15.50% | 32.63B | |
| -0.98% | +2.86% | +46.30% | +99.76% | 25.69B | |
| -1.09% | -1.38% | -0.30% | +161.62% | 22.49B | |
| +0.80% | -1.31% | +63.55% | +108.02% | 16.33B | |
| -0.87% | -6.99% | -21.81% | +774.82% | 14.79B | |
| Average | -0.60% | +0.04% | +64.13% | +131.14% | 40.95B | |
| Weighted average by Cap. | -0.65% | +0.96% | +82.39% | +67.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.55B 13.69B 12.49B 23.37B 1,600B 23.44B 162B 62.73B 820B 63.55B 62.16B 2,610B | 18.42B 15.84B 14.9B 13.6B 25.43B 1,742B 25.52B 177B 68.28B 892B 69.17B 67.65B 2,841B |
| Net income | 4.77B 4.11B 3.86B 3.52B 6.59B 451B 6.61B 45.78B 17.7B 231B 17.93B 17.53B 736B | 5.45B 4.68B 4.4B 4.02B 7.52B 515B 7.54B 52.22B 20.19B 264B 20.45B 20B 840B |
| Net Debt | -6.87B -5.91B -5.56B -5.07B -9.48B -650B -9.52B -65.87B -25.46B -333B -25.79B -25.23B -1,060B | -10.55B -9.08B -8.54B -7.79B -14.57B -998B -14.62B -101B -39.12B -511B -39.63B -38.77B -1,628B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | USD 827.72 | -1.87% | 561,170 |
| 03/09/26 | USD 843.47 | -1.00% | 496,255 |
| 02/09/26 | USD 852.03 | +3.42% | 749,453 |
| 01/09/26 | USD 823.82 | +3.10% | 682,806 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
